GENE THERAPY FOR EYE PATHOLOGIES
Compositions and methods are described for the delivery of therapeutic products (such as therapeutic proteins (for example, antibodies), therapeutic RNAs (for example, shRNAs, siRNAs, and miRNAs), and therapeutic aptamers) to the retina/vitreal humour in the eyes of human subjects to treat pathologi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DANOS, Olivier YOO, Jesse CURTISS, Darin VAN EVEREN, Sherri IRWIN-PACK, Kim GHANEKAR, Avanti O'BERRY, Anthony PATEL, Samir |
| description | Compositions and methods are described for the delivery of therapeutic products (such as therapeutic proteins (for example, antibodies), therapeutic RNAs (for example, shRNAs, siRNAs, and miRNAs), and therapeutic aptamers) to the retina/vitreal humour in the eyes of human subjects to treat pathologies of the eye, involving, for example, recombinant viral vectors such as recombinant adeno-associated virus (rAAV) vectors.
L'invention concerne des compositions et des méthodes destinées à l'administration de produits thérapeutiques (tels que des protéines thérapeutiques (par exemple, des anticorps), des ARN thérapeutiques (par exemple, ARNsi, des ARNsh et des miARN), et des aptamères thérapeutiques) dans la rétine/l'humeur vitrée des yeux de sujets humains pour traiter des pathologies de l'œil, impliquant, par exemple, des vecteurs viraux recombinés tels que des vecteurs de virus adéno-associés recombinés (rAAV). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2020206098A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2020206098A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2020206098A13</originalsourceid><addsrcrecordid>eNrjZFBwd_VzVQjxcA1yDIhUcPMPUnCNdFUIcAzx8Pfxd_d0DeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGIGhmYGnhaGhMnCoAcJEitg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GENE THERAPY FOR EYE PATHOLOGIES</title><source>esp@cenet</source><creator>DANOS, Olivier ; YOO, Jesse ; CURTISS, Darin ; VAN EVEREN, Sherri ; IRWIN-PACK, Kim ; GHANEKAR, Avanti ; O'BERRY, Anthony ; PATEL, Samir</creator><creatorcontrib>DANOS, Olivier ; YOO, Jesse ; CURTISS, Darin ; VAN EVEREN, Sherri ; IRWIN-PACK, Kim ; GHANEKAR, Avanti ; O'BERRY, Anthony ; PATEL, Samir</creatorcontrib><description>Compositions and methods are described for the delivery of therapeutic products (such as therapeutic proteins (for example, antibodies), therapeutic RNAs (for example, shRNAs, siRNAs, and miRNAs), and therapeutic aptamers) to the retina/vitreal humour in the eyes of human subjects to treat pathologies of the eye, involving, for example, recombinant viral vectors such as recombinant adeno-associated virus (rAAV) vectors.
L'invention concerne des compositions et des méthodes destinées à l'administration de produits thérapeutiques (tels que des protéines thérapeutiques (par exemple, des anticorps), des ARN thérapeutiques (par exemple, ARNsi, des ARNsh et des miARN), et des aptamères thérapeutiques) dans la rétine/l'humeur vitrée des yeux de sujets humains pour traiter des pathologies de l'œil, impliquant, par exemple, des vecteurs viraux recombinés tels que des vecteurs de virus adéno-associés recombinés (rAAV).</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201008&DB=EPODOC&CC=WO&NR=2020206098A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201008&DB=EPODOC&CC=WO&NR=2020206098A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DANOS, Olivier</creatorcontrib><creatorcontrib>YOO, Jesse</creatorcontrib><creatorcontrib>CURTISS, Darin</creatorcontrib><creatorcontrib>VAN EVEREN, Sherri</creatorcontrib><creatorcontrib>IRWIN-PACK, Kim</creatorcontrib><creatorcontrib>GHANEKAR, Avanti</creatorcontrib><creatorcontrib>O'BERRY, Anthony</creatorcontrib><creatorcontrib>PATEL, Samir</creatorcontrib><title>GENE THERAPY FOR EYE PATHOLOGIES</title><description>Compositions and methods are described for the delivery of therapeutic products (such as therapeutic proteins (for example, antibodies), therapeutic RNAs (for example, shRNAs, siRNAs, and miRNAs), and therapeutic aptamers) to the retina/vitreal humour in the eyes of human subjects to treat pathologies of the eye, involving, for example, recombinant viral vectors such as recombinant adeno-associated virus (rAAV) vectors.
L'invention concerne des compositions et des méthodes destinées à l'administration de produits thérapeutiques (tels que des protéines thérapeutiques (par exemple, des anticorps), des ARN thérapeutiques (par exemple, ARNsi, des ARNsh et des miARN), et des aptamères thérapeutiques) dans la rétine/l'humeur vitrée des yeux de sujets humains pour traiter des pathologies de l'œil, impliquant, par exemple, des vecteurs viraux recombinés tels que des vecteurs de virus adéno-associés recombinés (rAAV).</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBwd_VzVQjxcA1yDIhUcPMPUnCNdFUIcAzx8Pfxd_d0DeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGIGhmYGnhaGhMnCoAcJEitg</recordid><startdate>20201008</startdate><enddate>20201008</enddate><creator>DANOS, Olivier</creator><creator>YOO, Jesse</creator><creator>CURTISS, Darin</creator><creator>VAN EVEREN, Sherri</creator><creator>IRWIN-PACK, Kim</creator><creator>GHANEKAR, Avanti</creator><creator>O'BERRY, Anthony</creator><creator>PATEL, Samir</creator><scope>EVB</scope></search><sort><creationdate>20201008</creationdate><title>GENE THERAPY FOR EYE PATHOLOGIES</title><author>DANOS, Olivier ; YOO, Jesse ; CURTISS, Darin ; VAN EVEREN, Sherri ; IRWIN-PACK, Kim ; GHANEKAR, Avanti ; O'BERRY, Anthony ; PATEL, Samir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2020206098A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>DANOS, Olivier</creatorcontrib><creatorcontrib>YOO, Jesse</creatorcontrib><creatorcontrib>CURTISS, Darin</creatorcontrib><creatorcontrib>VAN EVEREN, Sherri</creatorcontrib><creatorcontrib>IRWIN-PACK, Kim</creatorcontrib><creatorcontrib>GHANEKAR, Avanti</creatorcontrib><creatorcontrib>O'BERRY, Anthony</creatorcontrib><creatorcontrib>PATEL, Samir</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DANOS, Olivier</au><au>YOO, Jesse</au><au>CURTISS, Darin</au><au>VAN EVEREN, Sherri</au><au>IRWIN-PACK, Kim</au><au>GHANEKAR, Avanti</au><au>O'BERRY, Anthony</au><au>PATEL, Samir</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GENE THERAPY FOR EYE PATHOLOGIES</title><date>2020-10-08</date><risdate>2020</risdate><abstract>Compositions and methods are described for the delivery of therapeutic products (such as therapeutic proteins (for example, antibodies), therapeutic RNAs (for example, shRNAs, siRNAs, and miRNAs), and therapeutic aptamers) to the retina/vitreal humour in the eyes of human subjects to treat pathologies of the eye, involving, for example, recombinant viral vectors such as recombinant adeno-associated virus (rAAV) vectors.
L'invention concerne des compositions et des méthodes destinées à l'administration de produits thérapeutiques (tels que des protéines thérapeutiques (par exemple, des anticorps), des ARN thérapeutiques (par exemple, ARNsi, des ARNsh et des miARN), et des aptamères thérapeutiques) dans la rétine/l'humeur vitrée des yeux de sujets humains pour traiter des pathologies de l'œil, impliquant, par exemple, des vecteurs viraux recombinés tels que des vecteurs de virus adéno-associés recombinés (rAAV).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2020206098A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | GENE THERAPY FOR EYE PATHOLOGIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T20%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DANOS,%20Olivier&rft.date=2020-10-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2020206098A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |